Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH.

Enormous efforts have been made in the past to identify novel scaffolds against the potential therapeutic target, Plasmodium falciparum dihydroorotate dehydrogenase (PfDHODH). Fourteen different organic molecules have been crystallized to understand the structural basis of the inhibition. However, the pharmacophoric studies carried out so far, have not exploited all the structural information simultaneously to identify the novel inhibitors. Therefore, an attempt was made to construct the pharmacophore hypotheses from the available PfDHODH structural proteome. Among the generated hypotheses, a representative hypothesis was employed as a primary filter to list the molecules with complimentary features accountable for inhibition. Moreover, the auxiliary evaluations of the filtered molecules were accomplished via docking and drug-likeness studies. Subsequently, the stability of the protein-ligand complex was evaluated by using molecular dynamics simulations (MDs). The molecular details of binding interactions of the potential hits were compared with the highly active experimental structure (5FI8) to seek the more potent candidates that can be targeted against PfDHODH. Overall, the combination of screening and stability procedures resulted in the identification of three potent candidates. The drug-likeness of these molecules lie within the acceptable range and consequently increased the opportunities for their development to new anti-malarials.

[1]  Mark E. Tuckerman,et al.  Reversible multiple time scale molecular dynamics , 1992 .

[2]  Farah El Mazouni,et al.  A long-duration dihydroorotate dehydrogenase inhibitor (DSM265) for prevention and treatment of malaria , 2015, Science Translational Medicine.

[3]  P. Leeson,et al.  The influence of drug-like concepts on decision-making in medicinal chemistry , 2007, Nature Reviews Drug Discovery.

[4]  Stephen R. Johnson,et al.  Molecular properties that influence the oral bioavailability of drug candidates. , 2002, Journal of medicinal chemistry.

[5]  Lisa Peltason,et al.  Molecular Similarity Analysis in Virtual Screening , 2009 .

[6]  T. N. Bhat,et al.  The Protein Data Bank , 2000, Nucleic Acids Res..

[7]  G J Williams,et al.  The Protein Data Bank: a computer-based archival file for macromolecular structures. , 1978, Archives of biochemistry and biophysics.

[8]  Hsuan-Liang Liu,et al.  The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies , 2011, Journal of Biomedical Science.

[9]  David M. Shackleford,et al.  A Triazolopyrimidine-Based Dihydroorotate Dehydrogenase Inhibitor with Improved Drug-like Properties for Treatment and Prevention of Malaria. , 2016, ACS infectious diseases.

[10]  Honglin Li,et al.  Novel selective and potent inhibitors of malaria parasite dihydroorotate dehydrogenase: discovery and optimization of dihydrothiophenone derivatives. , 2013, Journal of medicinal chemistry.

[11]  P. Rathod,et al.  High-throughput Screening for Potent and Selective Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2005, Journal of Biological Chemistry.

[12]  D. E. Clark Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena. 1. Prediction of intestinal absorption. , 1999, Journal of pharmaceutical sciences.

[13]  S. Henikoff,et al.  Amino acid substitution matrices from protein blocks. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[14]  P. Rathod,et al.  The X-ray structure of Plasmodium falciparum dihydroorotate dehydrogenase bound to a potent and selective N-phenylbenzamide inhibitor reveals novel binding-site interactions. , 2015, Acta crystallographica. Section F, Structural biology communications.

[15]  H. Simmonds,et al.  Pyrimidine pathways in health and disease. , 2005, Trends in molecular medicine.

[16]  A. Wadood,et al.  In silico identification of novel inhibitors against Plasmodium falciparum dihydroorate dehydrogenase. , 2013, Journal of molecular graphics & modelling.

[17]  Conrad C. Huang,et al.  Tools for integrated sequence-structure analysis with UCSF Chimera , 2006, BMC Bioinformatics.

[18]  Werner Kaminsky,et al.  Structural Plasticity of Malaria Dihydroorotate Dehydrogenase Allows Selective Binding of Diverse Chemical Scaffolds* , 2009, The Journal of Biological Chemistry.

[19]  Thomas Lengauer,et al.  A fast flexible docking method using an incremental construction algorithm. , 1996, Journal of molecular biology.

[20]  Santosh A. Khedkar,et al.  Pharmacophore modeling in drug discovery and development: an overview. , 2007, Medicinal chemistry (Shariqah (United Arab Emirates)).

[21]  T. Ritchie,et al.  The impact of aromatic ring count on compound developability--are too many aromatic rings a liability in drug design? , 2009, Drug discovery today.

[22]  Brian K. Shoichet,et al.  ZINC - A Free Database of Commercially Available Compounds for Virtual Screening , 2005, J. Chem. Inf. Model..

[23]  Daniela Schuster,et al.  Pharmacophore-based discovery of FXR agonists. Part I: Model development and experimental validation , 2011, Bioorganic & medicinal chemistry.

[24]  P. Tosco,et al.  New inhibitors of dihydroorotate dehydrogenase (DHODH) based on the 4-hydroxy-1,2,5-oxadiazol-3-yl (hydroxyfurazanyl) scaffold. , 2012, European journal of medicinal chemistry.

[25]  M. Karplus,et al.  CHARMM: A program for macromolecular energy, minimization, and dynamics calculations , 1983 .

[26]  Tom Fawcett,et al.  An introduction to ROC analysis , 2006, Pattern Recognit. Lett..

[27]  S. Nosé A unified formulation of the constant temperature molecular dynamics methods , 1984 .

[28]  Jeremy N. Burrows,et al.  Fluorine Modulates Species Selectivity in the Triazolopyrimidine Class of Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors , 2014, Journal of medicinal chemistry.

[29]  W. L. Jorgensen,et al.  Comparison of simple potential functions for simulating liquid water , 1983 .

[30]  David M. Shackleford,et al.  Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential. , 2011, Journal of medicinal chemistry.

[31]  Elaine S. Oran,et al.  A modified shake algorithm for maintaining rigid bonds in molecular dynamics simulations of large molecules , 1989 .

[32]  T Lengauer,et al.  CASP2 experiences with docking flexible ligands using FLEXX , 1997, Proteins.

[33]  David M. Shackleford,et al.  Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. , 2011, Journal of medicinal chemistry.

[34]  Bradley I. Coleman,et al.  Novel Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase with Anti-malarial Activity in the Mouse Model* , 2010, The Journal of Biological Chemistry.

[35]  D. Wirth,et al.  Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase* , 2008, Journal of Biological Chemistry.

[36]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[37]  F. Lombardo,et al.  Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .

[38]  Federico D. Sacerdoti,et al.  Scalable Algorithms for Molecular Dynamics Simulations on Commodity Clusters , 2006, ACM/IEEE SC 2006 Conference (SC'06).

[39]  Adrià Cereto-Massagué,et al.  DecoyFinder: an easy-to-use python GUI application for building target-specific decoy sets , 2012, Bioinform..

[40]  V. Barton,et al.  Novel inhibitors of the Plasmodium falciparum electron transport chain , 2014, Parasitology.

[41]  Andreas Bender,et al.  A Discussion of Measures of Enrichment in Virtual Screening: Comparing the Information Content of Descriptors with Increasing Levels of Sophistication , 2005, J. Chem. Inf. Model..

[42]  V. Vyas,et al.  Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. , 2013, Journal of molecular graphics & modelling.

[43]  Ling Wang,et al.  Three-Dimensional Pharmacophore Modeling of Liver-X Receptor Agonists , 2011, J. Chem. Inf. Model..

[44]  S. Planey,et al.  The influence of lipophilicity in drug discovery and design , 2012, Expert opinion on drug discovery.

[45]  P. Leeson,et al.  Drug discovery: Chemical beauty contest , 2012, Nature.

[46]  P. Rathod,et al.  Tetrahydro-2-naphthyl and 2-Indanyl Triazolopyrimidines Targeting Plasmodium falciparum Dihydroorotate Dehydrogenase Display Potent and Selective Antimalarial Activity , 2016, Journal of medicinal chemistry.

[47]  A. Christoffels,et al.  Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs , 2016, Malaria Journal.

[48]  V. Vyas,et al.  Identification of novel PfDHODH inhibitors as antimalarial agents via pharmacophore-based virtual screening followed by molecular docking and in vivo antimalarial activity , 2016, SAR and QSAR in environmental research.

[49]  V. Ram,et al.  Oxygenated chalcones and bischalcones as potential antimalarial agents. , 2000, Bioorganic & medicinal chemistry letters.

[50]  M. Klein,et al.  Constant pressure molecular dynamics algorithms , 1994 .

[51]  P. Rathod,et al.  Variations in frequencies of drug resistance in Plasmodium falciparum. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[52]  D. Fidock,et al.  K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates , 2015, Science.

[53]  Darrell E Hurt,et al.  Structure of Plasmodium falciparum dihydroorotate dehydrogenase with a bound inhibitor. , 2006, Acta crystallographica. Section D, Biological crystallography.

[54]  Joanne M. Morrisey,et al.  Specific role of mitochondrial electron transport in blood-stage Plasmodium falciparum , 2007, Nature.

[55]  Ramón García-Domenech,et al.  New agents active against Mycobacterium avium complex selected by molecular topology: a virtual screening method. , 2003, The Journal of antimicrobial chemotherapy.

[56]  Weltgesundheitsorganisation World malaria report , 2005 .

[57]  Osman F. Güner,et al.  Pharmacophore perception, development, and use in drug design , 2000 .

[58]  P. Rathod,et al.  Triazolopyrimidine-based dihydroorotate dehydrogenase inhibitors with potent and selective activity against the malaria parasite Plasmodium falciparum. , 2008, Journal of medicinal chemistry.

[59]  W. L. Jorgensen,et al.  Development and Testing of the OPLS All-Atom Force Field on Conformational Energetics and Properties of Organic Liquids , 1996 .

[60]  H. Berendsen,et al.  Molecular dynamics with coupling to an external bath , 1984 .

[61]  D. Wirth,et al.  In Vitro Resistance Selections for Plasmodium falciparum Dihydroorotate Dehydrogenase Inhibitors Give Mutants with Multiple Point Mutations in the Drug-binding Site and Altered Growth , 2014, The Journal of Biological Chemistry.

[62]  S. B. Needleman,et al.  A general method applicable to the search for similarities in the amino acid sequence of two proteins. , 1970, Journal of molecular biology.

[63]  M. Mobashir,et al.  Dihydroorotate dehydrogenase: A drug target for the development of antimalarials. , 2017, European journal of medicinal chemistry.

[64]  Hans-Joachim Böhm,et al.  The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure , 1994, J. Comput. Aided Mol. Des..

[65]  Ravinder Singh,et al.  Fast-Find: A novel computational approach to analyzing combinatorial motifs , 2006, BMC Bioinformatics.

[66]  T. Darden,et al.  Particle mesh Ewald: An N⋅log(N) method for Ewald sums in large systems , 1993 .